Kawase, K., K. Yoshida, K. Hara, S. Hidaka, and H. Takeyama. “Efficacy and Safety of Neoadjuvant Chemotherapy With Dose De-Escalation Tri-Weekly Nanoparticle Albumin-Bound Paclitaxel and FEC for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer”. Clinical Medicine Insights, vol. 4, no. 2, June 2023, pp. 378-86, doi:10.52845/CMI/2023-4-2-1.